Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Pan American Silver Corp. Common Stock (PAAS) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Pan American Silver Corp. Common StockTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Pan American Silver Corp. Common Stock — how do they compare? Ginkgo Bioworks Holdings Inc trades at $12.95 (market cap $763.64M), while Pan American Silver Corp. Common Stock trades at $46.32 (market cap $18.72B). The key difference: Pan American Silver Corp. Common Stock is far larger — about 24.5× Ginkgo Bioworks Holdings Inc's market cap, and Pan American Silver Corp. Common Stock pays a 1.62% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Pan American Silver Corp. Common Stock for 1 Days on average.

DNAPAAS
Market Cap
$763.64M$18.72B
Volume
3,204,1772,957,838
Sector
HealthBasic Materials
52-Week High
$15.83$68.70
52-Week Low
$5.48$33.20
Typical Hold Time
7 Days1 Days
Enterprise Value
$865.59M$17.86B
Dividend Yield
—1.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.

DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.

Pan American Silver Corp. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNA
47% Buy53% Sell
Avg holding period · 7 Days
PAAS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →

About Pan American Silver Corp. Common Stock

Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.

Read more on PAAS →